Cargando…

Feasibility analysis of combined surgery for esophageal cancer

BACKGROUND: As the preoperative examination of esophageal cancer has improved, the likelihood of finding diseases in other organs that require surgical treatment has also increased. The purpose of this study was to explore the feasibility of combined surgery for esophageal cancer by analyzing the oc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhulin, Sun, Shaowu, Li, Kaiyuan, Huang, Chunyao, Liu, Xu, Zhang, Guoqing, Li, Xiangnan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912580/
https://www.ncbi.nlm.nih.gov/pubmed/36765428
http://dx.doi.org/10.1186/s12957-023-02930-0
_version_ 1784885235538722816
author Wang, Zhulin
Sun, Shaowu
Li, Kaiyuan
Huang, Chunyao
Liu, Xu
Zhang, Guoqing
Li, Xiangnan
author_facet Wang, Zhulin
Sun, Shaowu
Li, Kaiyuan
Huang, Chunyao
Liu, Xu
Zhang, Guoqing
Li, Xiangnan
author_sort Wang, Zhulin
collection PubMed
description BACKGROUND: As the preoperative examination of esophageal cancer has improved, the likelihood of finding diseases in other organs that require surgical treatment has also increased. The purpose of this study was to explore the feasibility of combined surgery for esophageal cancer by analyzing the occurrence of postoperative complications in patients with esophageal cancer. METHODS: The clinical characteristics of 1566 patients with esophageal cancer who underwent thoracic surgery in our hospital between January 2017 and September 2022 were analyzed retrospectively. The feasibility of combined surgery for esophageal cancer was analyzed by comparing postoperative complications in patients who underwent simple esophageal cancer surgery (SEC) with those in patients who underwent combined surgery for esophageal cancer (COEC). The tendency scores of patients in the COEC and SEC groups (1:2) were matched to balance the confounding clinical factors, and the difference in postoperative complications was further analyzed. Moreover, we performed a subgroup analysis of esophagectomy combined with lung resection (ECL). In addition, the independent risk factors for postoperative Clavien–Dindo ≥ grade III complications of esophageal cancer were analyzed by multivariate logistic regression. RESULTS: A total of 1566 patients (1147 (73.2%) males and 419 (26.8%) females), with an average age of 64.2 years, were analyzed. There was no significant difference in postoperative complications between the SEC and COEC groups according to the Clavien-Dindo classification (P=0.713). An analysis of the complications revealed that those in the COEC group had a higher incidence of lung consolidation than those in the SEC group (P=0.007). However, when we performed propensity score matching (PSM) on the SEC and COEC groups, there was still no significant difference in complications according to the Clavien–Dindo classification (P=0.346); furthermore, when a detailed analysis of complications was performed, there was no significant difference between the two. In subgroup analysis, after we performed PSM in ECL patients and SEC patients, we also found no significant difference in postoperative complications between patients with ECL and patients with SEC. In addition, we found that a history of diabetes (OR=1.604, P=0.029, 95% CI=1.049–2.454), a history of coronary heart disease (OR=1.592, P=0.046, 95% CI=1.008–2.515), diffusing capacity of the lungs for carbon monoxide (DLCO) (OR=0.916, P=0.024, 95% CI=0.849–0.988), and ALB level (OR=0.955, P=0.007, 95% CI=0.924–0.987) were independent factors that influenced postoperative complications in esophageal cancer patients with grade III or higher complications. CONCLUSION: Combined surgery for esophageal cancer does not increase the incidence of postoperative complications. In addition, a history of diabetes mellitus or coronary heart disease, carbon monoxide dispersion, and preoperative ALB level are independent risk factors for grade III or higher postoperative complications of esophageal cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12957-023-02930-0.
format Online
Article
Text
id pubmed-9912580
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-99125802023-02-11 Feasibility analysis of combined surgery for esophageal cancer Wang, Zhulin Sun, Shaowu Li, Kaiyuan Huang, Chunyao Liu, Xu Zhang, Guoqing Li, Xiangnan World J Surg Oncol Research BACKGROUND: As the preoperative examination of esophageal cancer has improved, the likelihood of finding diseases in other organs that require surgical treatment has also increased. The purpose of this study was to explore the feasibility of combined surgery for esophageal cancer by analyzing the occurrence of postoperative complications in patients with esophageal cancer. METHODS: The clinical characteristics of 1566 patients with esophageal cancer who underwent thoracic surgery in our hospital between January 2017 and September 2022 were analyzed retrospectively. The feasibility of combined surgery for esophageal cancer was analyzed by comparing postoperative complications in patients who underwent simple esophageal cancer surgery (SEC) with those in patients who underwent combined surgery for esophageal cancer (COEC). The tendency scores of patients in the COEC and SEC groups (1:2) were matched to balance the confounding clinical factors, and the difference in postoperative complications was further analyzed. Moreover, we performed a subgroup analysis of esophagectomy combined with lung resection (ECL). In addition, the independent risk factors for postoperative Clavien–Dindo ≥ grade III complications of esophageal cancer were analyzed by multivariate logistic regression. RESULTS: A total of 1566 patients (1147 (73.2%) males and 419 (26.8%) females), with an average age of 64.2 years, were analyzed. There was no significant difference in postoperative complications between the SEC and COEC groups according to the Clavien-Dindo classification (P=0.713). An analysis of the complications revealed that those in the COEC group had a higher incidence of lung consolidation than those in the SEC group (P=0.007). However, when we performed propensity score matching (PSM) on the SEC and COEC groups, there was still no significant difference in complications according to the Clavien–Dindo classification (P=0.346); furthermore, when a detailed analysis of complications was performed, there was no significant difference between the two. In subgroup analysis, after we performed PSM in ECL patients and SEC patients, we also found no significant difference in postoperative complications between patients with ECL and patients with SEC. In addition, we found that a history of diabetes (OR=1.604, P=0.029, 95% CI=1.049–2.454), a history of coronary heart disease (OR=1.592, P=0.046, 95% CI=1.008–2.515), diffusing capacity of the lungs for carbon monoxide (DLCO) (OR=0.916, P=0.024, 95% CI=0.849–0.988), and ALB level (OR=0.955, P=0.007, 95% CI=0.924–0.987) were independent factors that influenced postoperative complications in esophageal cancer patients with grade III or higher complications. CONCLUSION: Combined surgery for esophageal cancer does not increase the incidence of postoperative complications. In addition, a history of diabetes mellitus or coronary heart disease, carbon monoxide dispersion, and preoperative ALB level are independent risk factors for grade III or higher postoperative complications of esophageal cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12957-023-02930-0. BioMed Central 2023-02-10 /pmc/articles/PMC9912580/ /pubmed/36765428 http://dx.doi.org/10.1186/s12957-023-02930-0 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Wang, Zhulin
Sun, Shaowu
Li, Kaiyuan
Huang, Chunyao
Liu, Xu
Zhang, Guoqing
Li, Xiangnan
Feasibility analysis of combined surgery for esophageal cancer
title Feasibility analysis of combined surgery for esophageal cancer
title_full Feasibility analysis of combined surgery for esophageal cancer
title_fullStr Feasibility analysis of combined surgery for esophageal cancer
title_full_unstemmed Feasibility analysis of combined surgery for esophageal cancer
title_short Feasibility analysis of combined surgery for esophageal cancer
title_sort feasibility analysis of combined surgery for esophageal cancer
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912580/
https://www.ncbi.nlm.nih.gov/pubmed/36765428
http://dx.doi.org/10.1186/s12957-023-02930-0
work_keys_str_mv AT wangzhulin feasibilityanalysisofcombinedsurgeryforesophagealcancer
AT sunshaowu feasibilityanalysisofcombinedsurgeryforesophagealcancer
AT likaiyuan feasibilityanalysisofcombinedsurgeryforesophagealcancer
AT huangchunyao feasibilityanalysisofcombinedsurgeryforesophagealcancer
AT liuxu feasibilityanalysisofcombinedsurgeryforesophagealcancer
AT zhangguoqing feasibilityanalysisofcombinedsurgeryforesophagealcancer
AT lixiangnan feasibilityanalysisofcombinedsurgeryforesophagealcancer